These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16718903)

  • 21. Current developments in HIV chemotherapy.
    Meadows DC; Gervay-Hague J
    ChemMedChem; 2006 Jan; 1(1):16-29. PubMed ID: 16892329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The design of drugs for HIV and HCV.
    De Clercq E
    Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The state of the science of HIV treatment approaches.
    Follansbee SE
    Focus; 2007 Jan; 22(1):1-5. PubMed ID: 17526105
    [No Abstract]   [Full Text] [Related]  

  • 24. The ninth annual HIV drug guide.
    Posit Aware; 2005; 16(1):21-47. PubMed ID: 17390504
    [No Abstract]   [Full Text] [Related]  

  • 25. The eighth annual HIV drug guide.
    Clifton CE; Vázquez E
    Posit Aware; 2004; 15(1):16-40. PubMed ID: 14989196
    [No Abstract]   [Full Text] [Related]  

  • 26. New targets bring new challenges.
    Huff B
    GMHC Treat Issues; 2002 Mar; 16(3):4-6. PubMed ID: 12004798
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-HIV agents. New drugs in the pipeline.
    TreatmentUpdate; 2003; 15(2):1-3. PubMed ID: 12691045
    [No Abstract]   [Full Text] [Related]  

  • 28. New HIV drugs needed for the next decade.
    Huff B
    GMHC Treat Issues; 2006; 20(4-7):1-3. PubMed ID: 17228447
    [No Abstract]   [Full Text] [Related]  

  • 29. Treat the world.
    Huff B
    GMHC Treat Issues; 2005; 19(3-4):6-10. PubMed ID: 16003844
    [No Abstract]   [Full Text] [Related]  

  • 30. [New therapeutic strategies. Many of the trails have not yet been validated].
    Delfraissy JF
    Med Mal Infect; 2006 Jul; 36 Suppl 2():S224-30. PubMed ID: 17076001
    [No Abstract]   [Full Text] [Related]  

  • 31. New formulations, new drugs...not always better.
    Sharp M
    Posit Aware; 2003; 14(5):20-2. PubMed ID: 14679937
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV research: Casting a wide net.
    Kiser K
    Minn Med; 2009 Oct; 92(10):8-10. PubMed ID: 19916266
    [No Abstract]   [Full Text] [Related]  

  • 33. Botswana gets boost in AIDS funding.
    AIDS Patient Care STDS; 2010 Oct; 24(10):685. PubMed ID: 20945534
    [No Abstract]   [Full Text] [Related]  

  • 34. A different class: new HIV therapies on the horizon.
    Sharp M
    Posit Aware; 2003; 14(3):14-5. PubMed ID: 12866484
    [No Abstract]   [Full Text] [Related]  

  • 35. Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion.
    Corales RB; Djeloski DS; Mancenido MD; Valenti WM
    AIDS Read; 2009 Feb; 19(2):62-4, 70-4, 78. PubMed ID: 19271330
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on new antiretroviral drugs. An interview with Harold Kessler, M.D. by Matt Sharp.
    Kessler H
    Posit Aware; 2007; 18(6):22-4. PubMed ID: 18074429
    [No Abstract]   [Full Text] [Related]  

  • 37. Twenty-five years in the fight against AIDS: what have we learned?
    Proj Inf Perspect; 2006 Oct; (42):1-3. PubMed ID: 17162804
    [No Abstract]   [Full Text] [Related]  

  • 38. [The point of therapy].
    Ramé A
    Rev Infirm; 2006 Dec; (126):14-5. PubMed ID: 17269294
    [No Abstract]   [Full Text] [Related]  

  • 39. Aluvia tablet approved in 19 African countries.
    AIDS Patient Care STDS; 2007 Aug; 21(8):604-5. PubMed ID: 17902244
    [No Abstract]   [Full Text] [Related]  

  • 40. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.